|
1
|
Gender differences in time spent on parenting and domestic responsibilities by high-achieving young physician-researchers.
|
Ann Intern Med
|
2014
|
4.76
|
|
2
|
Sex differences in attainment of independent funding by career development awardees.
|
Ann Intern Med
|
2009
|
4.62
|
|
3
|
Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
|
J Clin Oncol
|
2006
|
3.79
|
|
4
|
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
|
Blood
|
2012
|
3.44
|
|
5
|
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
|
Int J Radiat Oncol Biol Phys
|
2006
|
3.40
|
|
6
|
Gender differences in salary in a recent cohort of early-career physician-researchers.
|
Acad Med
|
2013
|
2.68
|
|
7
|
Gender differences in the salaries of physician researchers.
|
JAMA
|
2012
|
2.66
|
|
8
|
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
2.33
|
|
9
|
Similarities and differences in the career trajectories of male and female career development award recipients.
|
Acad Med
|
2011
|
1.81
|
|
10
|
Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.
|
Cancer
|
2007
|
1.76
|
|
11
|
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
|
Ann Surg Oncol
|
2006
|
1.75
|
|
12
|
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.67
|
|
13
|
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
|
Cancer
|
2007
|
1.64
|
|
14
|
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial.
|
Leuk Lymphoma
|
2011
|
1.57
|
|
15
|
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo.
|
Neoplasia
|
2006
|
1.55
|
|
16
|
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
|
Breast Cancer Res Treat
|
2005
|
1.49
|
|
17
|
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
|
Surgery
|
2007
|
1.47
|
|
18
|
Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.
|
Gynecol Oncol
|
2005
|
1.45
|
|
19
|
High-risk surgically resected pediatric melanoma and adjuvant interferon therapy.
|
Pediatr Blood Cancer
|
2005
|
1.43
|
|
20
|
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
|
Cancer Res
|
2005
|
1.41
|
|
21
|
Work-life balance in academic medicine: narratives of physician-researchers and their mentors.
|
J Gen Intern Med
|
2013
|
1.37
|
|
22
|
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.33
|
|
23
|
Mentoring and the career satisfaction of male and female academic medical faculty.
|
Acad Med
|
2014
|
1.31
|
|
24
|
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
|
Breast Cancer Res Treat
|
2005
|
1.30
|
|
25
|
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.
|
Clin Cancer Res
|
2013
|
1.20
|
|
26
|
Features predicting sentinel lymph node positivity in Merkel cell carcinoma.
|
J Clin Oncol
|
2011
|
1.16
|
|
27
|
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
|
Cancer
|
2013
|
1.16
|
|
28
|
Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.13
|
|
29
|
Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.
|
Blood
|
2011
|
1.11
|
|
30
|
Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life.
|
Cancer
|
2003
|
1.10
|
|
31
|
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
|
Breast Cancer Res Treat
|
2010
|
1.10
|
|
32
|
Role of radiotherapy in the management of desmoid tumors.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.10
|
|
33
|
Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
|
Gynecol Oncol
|
2007
|
1.09
|
|
34
|
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.07
|
|
35
|
Toxicity of radiotherapy in patients with collagen vascular disease.
|
Cancer
|
2008
|
1.06
|
|
36
|
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.
|
J Clin Oncol
|
2014
|
1.06
|
|
37
|
Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells.
|
BMC Complement Altern Med
|
2007
|
1.04
|
|
38
|
Is there a dose-response relationship for heart disease with low-dose radiation therapy?
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.04
|
|
39
|
Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.03
|
|
40
|
Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer.
|
J Clin Oncol
|
2006
|
1.03
|
|
41
|
Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
|
Gynecol Oncol
|
2007
|
1.02
|
|
42
|
Analytic morphometric assessment of patients undergoing colectomy for colon cancer.
|
J Surg Oncol
|
2013
|
1.02
|
|
43
|
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results.
|
Cancer
|
2003
|
1.01
|
|
44
|
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients.
|
Cancer
|
2003
|
1.00
|
|
45
|
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
|
Diagn Cytopathol
|
2006
|
0.98
|
|
46
|
A Mixed-Methods Investigation of the Motivations, Goals, and Aspirations of Male and Female Academic Medical Faculty.
|
Acad Med
|
2016
|
0.98
|
|
47
|
The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.
|
Neurosurgery
|
2004
|
0.96
|
|
48
|
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
|
Am J Clin Oncol
|
2007
|
0.96
|
|
49
|
Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases.
|
Sarcoma
|
2013
|
0.95
|
|
50
|
Gender differences in resources and negotiation among highly motivated physician-scientists.
|
J Gen Intern Med
|
2014
|
0.95
|
|
51
|
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
|
Cancer
|
2009
|
0.94
|
|
52
|
Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy.
|
Ann Surg Oncol
|
2011
|
0.94
|
|
53
|
Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.93
|
|
54
|
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.93
|
|
55
|
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.
|
Invest New Drugs
|
2008
|
0.93
|
|
56
|
Rate of freeze alters the immunologic response after cryoablation of breast cancer.
|
Ann Surg Oncol
|
2009
|
0.93
|
|
57
|
Correlates of mammogram density in southwestern Native-American women.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.90
|
|
58
|
Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
|
Ann Surg Oncol
|
2006
|
0.90
|
|
59
|
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience.
|
Breast J
|
2007
|
0.89
|
|
60
|
The identification of empirically derived cancer patient subgroups using psychosocial variables.
|
J Psychosom Res
|
2004
|
0.89
|
|
61
|
Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
|
Cancer
|
2011
|
0.88
|
|
62
|
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.87
|
|
63
|
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.87
|
|
64
|
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
|
Cancer
|
2007
|
0.87
|
|
65
|
Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska Native women.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.86
|
|
66
|
Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
|
Cancer
|
2006
|
0.86
|
|
67
|
Radiotherapy for pancreatic neuroendocrine tumors.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.85
|
|
68
|
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
|
Clin Cancer Res
|
2007
|
0.85
|
|
69
|
Quantifying dose to the reconstructed breast: can we adequately treat?
|
Med Dosim
|
2012
|
0.85
|
|
70
|
Radiotherapy using a water bath in the treatment of Bowen's disease of the digit.
|
Radiother Oncol
|
2008
|
0.85
|
|
71
|
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.85
|
|
72
|
Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis.
|
Am J Surg Pathol
|
2005
|
0.85
|
|
73
|
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.
|
Cancer
|
2007
|
0.84
|
|
74
|
Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
|
Urology
|
2003
|
0.84
|
|
75
|
Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort.
|
Dermatol Surg
|
2013
|
0.83
|
|
76
|
Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
|
Cancer
|
2008
|
0.82
|
|
77
|
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
|
Urology
|
2004
|
0.82
|
|
78
|
Generation of a tumor-specific systemic response after intratumoral injection of IL-12 and IL-18-loaded polylactic acid microspheres.
|
J Immunother
|
2007
|
0.82
|
|
79
|
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.82
|
|
80
|
Surgeons' knowledge and practices regarding the role of radiation therapy in breast cancer management.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.81
|
|
81
|
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.
|
Cancer Chemother Pharmacol
|
2005
|
0.81
|
|
82
|
Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed?
|
Diagn Cytopathol
|
2007
|
0.80
|
|
83
|
Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
|
Ann Surg Oncol
|
2008
|
0.79
|
|
84
|
Phase II trial of cetuximab in patients with metastatic or locally advanced soft tissue or bone sarcoma.
|
Am J Clin Oncol
|
2013
|
0.79
|
|
85
|
Dysplasia in Barrett esophagus.
|
Cancer
|
2004
|
0.78
|
|
86
|
Clinical utility of serum autoantibodies detected by protein microarray in melanoma.
|
Int J Proteomics
|
2011
|
0.77
|
|
87
|
Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.76
|
|
88
|
A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.
|
Am J Clin Oncol
|
2015
|
0.75
|
|
89
|
Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.75
|
|
90
|
Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|
|
91
|
Factors Associated With Success of Clinician-Researchers Receiving Career Development Awards From the National Institutes of Health: A Longitudinal Cohort Study.
|
Acad Med
|
2017
|
0.75
|